Stryker Corporation
Bear Case (25th pct.)
-66.7% vs price
Base Case (Median)
-52.2% vs price
Bull Case (75th pct.)
-46.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $47.00 | -86.0% | High (40%) |
| PE Comparable | $192.36 | -42.9% | Medium (25%) |
| Growth Trajectory DCF | $161.03 | -52.2% | Medium (20%) |
| Graham Number | $106.79 | -68.3% | Medium (40%) |
| EV/EBITDA | $165.20 | -51.0% | Medium (20%) |
| EV/FCF | $239.19 | -29.0% | Medium (20%) |
| Earnings Power Value | $117.47 | -65.1% | Medium (50%) |
Based on 7 out of 8 methods, SYK appears overvalued at the current price of $336.84. The base case fair value of $161.03 implies 52.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.